These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 30689671

  • 1. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS, Oldenburg CE, Cooley G, Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Keenan JD, Gaynor BD, Porco TC, Lietman TM, Martin DL.
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [Abstract] [Full Text] [Related]

  • 2. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
    Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Porco TC, Keenan JD, Lietman TM, Oldenburg CE.
    Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
    [Abstract] [Full Text] [Related]

  • 3. Serology for trachoma surveillance after cessation of mass drug administration.
    Martin DL, Bid R, Sandi F, Goodhew EB, Massae PA, Lasway A, Philippin H, Makupa W, Molina S, Holland MJ, Mabey DC, Drakeley C, Lammie PJ, Solomon AW.
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003555. PubMed ID: 25714363
    [Abstract] [Full Text] [Related]

  • 4. Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units.
    Burr SE, Hart J, Samikwa L, Chaima D, Cooley G, Martin D, Masika M, Solomon AW, Bailey RL, Kalua K.
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007749. PubMed ID: 31658258
    [Abstract] [Full Text] [Related]

  • 5. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A, Kadri B, Nassirou B, Stoller NE, Yu SN, Zhou Z, Chin S, West SK, Bailey RL, Mabey DC, Keenan JD, Porco TC, Lietman TM, Gaynor BD, PRET Partnership.
    PLoS Negl Trop Dis; 2012 Oct; 6(4):e1586. PubMed ID: 22545165
    [Abstract] [Full Text] [Related]

  • 6. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD, Tadesse Z, Gebresillasie S, Shiferaw A, Zerihun M, Emerson PM, Callahan K, Cotter SY, Stoller NE, Porco TC, Oldenburg CE, Lietman TM.
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [Abstract] [Full Text] [Related]

  • 7. Control of Trachoma from Achham District, Nepal: A Cross-Sectional Study from the Nepal National Trachoma Program.
    Pant BP, Bhatta RC, Chaudhary JS, Awasthi S, Mishra S, Sharma S, Cuddapah PA, Gwyn SE, Stoller NE, Martin DL, Keenan JD, Lietman TM, Gaynor BD.
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004462. PubMed ID: 26871898
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for ocular chlamydia after three mass azithromycin distributions.
    Ayele B, Gebre T, Moncada J, House JI, Stoller NE, Zhou Z, Porco TC, Gaynor BD, Emerson PM, Schachter J, Keenan JD.
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1441. PubMed ID: 22180804
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati.
    Cama A, Müller A, Taoaba R, Butcher RMR, Itibita I, Migchelsen SJ, Kiauea T, Pickering H, Willis R, Roberts CH, Bakhtiari A, Le Mesurier RT, Alexander NDE, Martin DL, Tekeraoi R, Solomon AW, Global Trachoma Mapping Project.
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005863. PubMed ID: 28898240
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N, Goodhew B, Mkocha H, Joseph K, Bandea C, Black C, Igietseme J, Munoz B, West SK, Lammie P, Kasubi M, Martin DL.
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [Abstract] [Full Text] [Related]

  • 11. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
    Arzika AM, Mindo-Panusis D, Abdou A, Kadri B, Nassirou B, Maliki R, Alsoudi AF, Zhang T, Cotter SY, Lebas E, O'Brien KS, Callahan EK, Bailey RL, West SK, Goodhew EB, Martin DL, Arnold BF, Porco TC, Lietman TM, Keenan JD, Macrolides Oraux pour Réduire les Décés Avec un Oeil sur la Resistance (MORDOR)–Niger Study Group.
    JAMA Netw Open; 2022 Aug 01; 5(8):e2228244. PubMed ID: 35997979
    [Abstract] [Full Text] [Related]

  • 12. The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma.
    Gwyn S, Nute AW, Sata E, Tadesse Z, Chernet A, Haile M, Zeru T, Bethea D, Laurent C, Callahan EK, Nash SD, Martin DL.
    Am J Trop Med Hyg; 2021 Aug 16; 105(5):1362-1367. PubMed ID: 34398819
    [Abstract] [Full Text] [Related]

  • 13. The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.
    Amza A, Kadri B, Nassirou B, Yu SN, Stoller NE, Bhosai SJ, Zhou Z, McCulloch CE, West SK, Bailey RL, Keenan JD, Lietman TM, Gaynor BD.
    PLoS Negl Trop Dis; 2013 Aug 16; 7(1):e1983. PubMed ID: 23326612
    [Abstract] [Full Text] [Related]

  • 14. CT694 and pgp3 as serological tools for monitoring trachoma programs.
    Goodhew EB, Priest JW, Moss DM, Zhong G, Munoz B, Mkocha H, Martin DL, West SK, Gaydos C, Lammie PJ.
    PLoS Negl Trop Dis; 2012 Aug 16; 6(11):e1873. PubMed ID: 23133684
    [Abstract] [Full Text] [Related]

  • 15. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP, Alemayehu W, Melese M, Lakew T, Sisay A, Zhou Z, Cevallos V, Oldenburg CE, Porco TC, Lietman TM, Keenan JD.
    Ophthalmic Epidemiol; 2019 Feb 16; 26(1):19-26. PubMed ID: 30153085
    [Abstract] [Full Text] [Related]

  • 16. Serological Responses to Trachoma Antigens prior to the Start of Mass Drug Administration: Results from Population-Based Baseline Surveys, North Darfur, Sudan.
    Sanders AM, Elshafie BE, Abdalla Z, Simmons C, Goodhew EB, Gonzalez TA, Nute AW, Mohammed A, Callahan EK, Martin DL, Nash SD.
    Am J Trop Med Hyg; 2024 Sep 03; 111(3_Suppl):49-57. PubMed ID: 38507810
    [Abstract] [Full Text] [Related]

  • 17. Serological and PCR-based markers of ocular Chlamydia trachomatis transmission in northern Ghana after elimination of trachoma as a public health problem.
    Senyonjo LG, Debrah O, Martin DL, Asante-Poku A, Migchelsen SJ, Gwyn S, deSouza DK, Solomon AW, Agyemang D, Biritwum-Kwadwo N, Marfo B, Bakajika D, Mensah EO, Aboe A, Koroma J, Addy J, Bailey R.
    PLoS Negl Trop Dis; 2018 Dec 03; 12(12):e0007027. PubMed ID: 30550537
    [Abstract] [Full Text] [Related]

  • 18. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM, Ayele B, Gebre T, Zerihun M, Tadesse Z, Emerson PM, Nash SD, Porco TC, Keenan JD, Oldenburg CE.
    Am J Ophthalmol; 2020 Jun 03; 214():143-150. PubMed ID: 32171768
    [Abstract] [Full Text] [Related]

  • 19. Surveillance Surveys for Reemergent Trachoma in Formerly Endemic Districts in Nepal From 2 to 10 Years After Mass Drug Administration Cessation.
    West SK, Zambrano AI, Sharma S, Mishra SK, Muñoz BE, Dize L, Crowley K, Gaydos CA, Rotondo LA.
    JAMA Ophthalmol; 2017 Nov 01; 135(11):1141-1146. PubMed ID: 28973295
    [Abstract] [Full Text] [Related]

  • 20. Ocular Chlamydia trachomatis infection: elimination with mass drug administration.
    Wolle MA, West SK.
    Expert Rev Anti Infect Ther; 2019 Mar 01; 17(3):189-200. PubMed ID: 30698042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.